487 filings
Page 7 of 25
6-K
cmj55pxuzefbf7iuzxu
7 Jun 22
Report of Foreign Private Issuer
5:00pm
6-K
il9axz9m6j8 aejox
19 May 22
Report of Foreign Private Issuer
8:00am
6-K
mb65i02vdiq55ciaqi
17 May 22
Report of Foreign Private Issuer
8:32am
424B3
vd8uywb1wx3rr7pims33
17 May 22
Prospectus supplement
8:30am
SC 13D/A
m3xdrm
13 May 22
Altamira Therapeutics / Meyer Thomas ownership change
8:32am
EFFECT
jtisoo phriwy6u
26 Apr 22
Notice of effectiveness
12:15am
424B3
ux8carjs4k
25 Apr 22
Prospectus supplement
5:09pm
CORRESP
945zcnqhcwl7m nmarhz
22 Apr 22
Correspondence with SEC
12:00am
EFFECT
2a47bt9zxax g3
20 Apr 22
Notice of effectiveness
12:15am
UPLOAD
9f0jfl 23t
20 Apr 22
Letter from SEC
12:00am
6-K
c7dfjx2e vv
18 Apr 22
Notice of the Annual General Meeting of Shareholders
7:30am
F-3
a32ustxzbr9d09vj
14 Apr 22
Shelf registration (foreign)
4:53pm
POS AM
dmq8hj
14 Apr 22
Prospectus update (post-effective amendment)
4:52pm
6-K
v9gwlfrtbh v705n
4 Mar 22
Altamira Therapeutics and Nuance Pharma Enter into Exclusive Licensing and Distribution Agreement for Bentrioâ„¢ in China and Additional Asian Markets
4:01pm
EFFECT
a25cn6uc ho15td1
18 Feb 22
Notice of effectiveness
12:15am
424B3
tkcf8d w4g92vxj4
17 Feb 22
Prospectus supplement
4:07pm
CORRESP
gtbphlpp qgftn
15 Feb 22
Correspondence with SEC
12:00am
UPLOAD
fpe0dl8zimsafd3xavq
14 Feb 22
Letter from SEC
12:00am
F-1
vnsuk
8 Feb 22
Registration statement (foreign)
5:11pm